Objective: The purpose of this study was to evaluate the F-fluorodeoxyglucose (FDG) positron emission tomography (PET) uptake in pulmonary lymphangitic carcinomatosis identified on computed tomography (CT) in patients with lung cancer.
Methods: This was a retrospective analysis of F-FDG PET images in 7 patients (4 male and 3 female, mean age: 56.6 +/- 6.6 years) with lung cancer with a CT-based diagnosis of lymphangitic carcinomatosis. The F-FDG PET scans in a group of 7 patients (4 male and 3 female, mean age: 42.1 +/- 5.66 years) with normal chest CT scans served as a control group. Mean standardized uptake values (SUVs) were calculated based on average tumor uptake, initial injected activity, and body weight.
Results: The intensity of F-FDG uptake in diseased lung is significantly greater than in corresponding normal contralateral lung or in the lungs of normal controls (P = 0.003). The ratio of the SUV of lung with lymphangitic carcinomatosis to corresponding contralateral normal lung was significantly increased (P = 0.006), and the ratio of the SUV of mediastinal blood pool to lung with lymphangitic carcinomatosis was significantly decreased (P = 0.0002).
Conclusion: There is diffuse increased FDG uptake in the lung corresponding to the CT pattern of lymphangitic carcinomatosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.rct.0000163952.03192.ef | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary signet ring cell carcinoma of the lung in patient with superior vena cava syndrome and lymphangitic carcinomatosis: a case report.
Intern Emerg Med
January 2025
Department of Clinical and Experimental Medicine, Internal Medicine Unit, University of Catania, University Hospital G.Rodolico, Catania, Italy.
The burden of medical contraindications to corneal donation: Time for review.
PLOS Glob Public Health
December 2024
Laboratory Biology, Engineering and Imaging for Ophthalmology, Health Innovation Campus, Faculty of Medicine, University Jean Monnet, Saint-Etienne, France.
Corneal graft (keratoplasty) is the most common allograft in the world, but the imbalance between the number of donors and the number of patients waiting for transplants is abysmal on a global scale and varies enormously from one country to another. The risk of transmission of systemic diseases from donor to recipient is demonstrably low. In over 50 years and an estimated 2.
View Article and Find Full Text PDFLymphangitic Carcinomatosis Presenting as Cough: A Case of Occult Metastatic Prostate Adenocarcinoma.
Case Rep Oncol Med
November 2024
Hematology/Oncology, Riverside University Health System, Moreno Valley, California, USA.
Article Synopsis
- Lymphangitic carcinomatosis (LC) is a serious condition often seen in advanced metastatic cancers, especially affecting the lungs, and presents symptoms like coughing and difficulty breathing.
- A 70-year-old man with generally good health experienced a persistent dry cough and other symptoms, leading to a diagnosis of Stage 4 prostate cancer with rare lung involvement.
- Imaging and biopsy confirmed the diagnosis, raising concerns for LC, which prompted urgent chemotherapy, highlighting the rarity of this condition in prostate cancer and its poor prognosis.
Low-dose apatinib in combination with chemotherapy for hormone receptor-positive, HER2-negative breast cancer with pulmonary lymphangitic carcinomatosis: A case report.
Medicine (Baltimore)
November 2024
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China.
Article Synopsis
- - A 48-year-old woman with hormone receptor-positive, HER2-negative advanced breast cancer developed pulmonary lymphangitic carcinomatosis (PLC) after ineffective treatment for a persistent cough.
- - She was treated with a combination of low-dose apatinib, capecitabine, and albumin-bound paclitaxel, which led to a partial response and improved symptoms over ten months.
- - This case suggests that apatinib may be a promising treatment for breast cancer patients with PLC, highlighting the need for tailored therapies and further research in this area.
99mTc-PSMA and 99mTc-FAPI-46 Uptake in Pulmonary Lymphangitic Carcinomatosis: A Rare Form of Metastasis in Prostate Cancer Patient, Responding to Modified Treatments.
Clin Nucl Med
December 2024
Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
This case report presents a rare instance of pulmonary lymphangitic carcinomatosis (PLC) in a prostate cancer patient, showcasing uptake of 99mTc-prostate-specific membrane antigen and 99mTc-fibroblast activation protein inhibitor-46 on imaging scans. A 70-year-old man with elevated serum prostate-specific antigen (PSA) levels exhibited respiratory symptoms and was diagnosed with widespread skeletal and pulmonary metastases. Following taxane-based chemotherapy and androgen deprivation therapy, imaging revealed decreased uptake and improvement in clinical symptoms, indicating treatment response.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!